RocketTickers

Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® L

Long
NASDAQ:SUPN   Supernus Pharmaceuticals, Inc
SUPN: Supernus Pharmaceuticals , Inc.
2018-12-14 16:02:00
Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® Label to Include Monotherapy